Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

Statins may help treat alopecia areata by reducing harmful immune interactions.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Isoquercitrin helps hair grow by activating certain cell processes.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Finasteride helps female-pattern hair loss.

iNKT cells help develop and maintain healthy skin in young mice.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Injectable platelet-rich fibrin is better than platelet-rich plasma for promoting hair growth.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.